Blog
42 Articles
RASolute 302 Trial for KRAS and Other RAS Mutations Recruiting at Multiple Sites
Dr. Hani Babiker is optimistic about the new drug to treat patients with KRAS mutations, now in a phase III trial.
Determined to Win
After a metastatic pancreatic cancer diagnosis, Linda Chambless sought a second opinion, which led her to a clinical trial.
Testing a Virus to Help Kill Pancreatic Tumor Cells
Researchers are testing whether cold virus can penetrate the tumor stroma and help kill pancreatic cancer cells.
More Effective Treatment for Metastatic Pancreatic Cancer
A worldwide clinical trial is testing a new drug combined with standard treatment, for patients with metastatic pancreatic cancer.
Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer
Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.
New FDA Approval Brings More Treatment Options in Metastatic Disease
The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.
A New Immunotherapy Drug to Make Chemotherapy More Effective for Metastatic Pancreatic Cancer
Researchers are testing a new immunotherapy drug to make standard chemotherapy more effective for metastatic pancreatic cancer.
Treating High Blood Sugar in People With Pancreatic Cancer
A new clinical trial explores the effectiveness of the drug glipizide in controlling high blood sugar in pancreatic cancer patients.
Targeted Protein Degradation to Treat Advanced Solid Tumors
A clinical trial tests the effectiveness of a molecule that causes protein degradation in tumor cells, including pancreatic cancer cells.
A New Approach to Immunotherapy for Advanced Pancreatic Cancer
Will a new type of immunotherapy help prevent tumors from developing resistance to chemotherapy? Research is underway.
A New Treatment for Progressive Metastatic Pancreatic Cancer
Researchers are testing a new drug for second-line therapy (after initial treatment stops working) in metastatic pancreatic cancer.
Brain Cancer Vaccine for Metastatic PNET
Researchers are testing a vaccine for PNET that targets a protein that is very abundant in many neuroendocrine tumors.
Research Updates from ASCO GI 2023
Read the latest clinical trial and research updates from the 2023 ASCO GI meeting, including a review of genetic testing uptake.
NAPOLI-3 Trial Meets Primary Endpoint in Metastatic Disease
Dr. Tanios Bekaii-Saab explains the early positive results from the NAPOLI-3 clinical trial, testing the NALIRIFOX combination.
More Effective Radiotherapy for Advanced Pancreatic Cancer Patients
Researchers are testing a drug that penetrates the stroma, to make radiotherapy work better for advanced pancreatic cancer patients.